Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
暂无分享,去创建一个
T. Willson | C. Glass | M. Lambert | M. Milburn | M. Rosenfeld | G. B. Wisely | R. Kurokawa | R. Nolte | S. Westin | J. Cobb | J. Cobb | G. Wisely
[1] Timothy,et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors (cid:97) and (cid:103) , 1997 .
[2] M. Lazar,et al. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. , 1994, Endocrinology.
[3] David M. Heery,et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors , 1997, Nature.
[4] Christopher K. Glass,et al. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation , 1998, Nature.
[5] M. Garabedian,et al. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors , 1997, Molecular and cellular biology.
[6] V. Chatterjee,et al. Functional analysis of a transactivation domain in the thyroid hormone beta receptor. , 1994, The Journal of biological chemistry.
[7] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[8] K. Umesono,et al. Unique response pathways are established by allosteric interactions among nuclear hormone receptors , 1995, Cell.
[9] Christopher K. Glass,et al. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function , 1997, Nature.
[10] Thorsten Heinzel,et al. A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.
[11] E. Kalkhoven,et al. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors , 1997, Molecular and cellular biology.
[12] H. Gronemeyer,et al. The coactivator TIF2 contains three nuclear receptor‐binding motifs and mediates transactivation through CBP binding‐dependent and ‐independent pathways , 1998, The EMBO journal.
[13] B. Spiegelman,et al. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor , 1994, Cell.
[14] J. Lees,et al. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.
[15] B. Spiegelman,et al. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.
[16] C. Glass,et al. Nuclear receptor coactivators. , 2000, Advances in pharmacology.
[17] R. Evans,et al. Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.
[18] William Bourguet,et al. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α , 1995, Nature.
[19] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[20] Zbigniew Dauter,et al. Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.
[21] K. Horwitz,et al. Nuclear receptor coactivators and corepressors. , 1996, Molecular endocrinology.
[22] S. Farmer,et al. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids , 1996, Molecular and cellular biology.
[23] W Furey,et al. PHASES-95: a program package for processing and analyzing diffraction data from macromolecules. , 1997, Methods in enzymology.
[24] R. Evans,et al. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.
[25] P. Meltzer,et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. , 1997, Science.
[26] P. Chambon,et al. Activation function 2 (AF‐2) of retinoic acid receptor and 9‐cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF‐2 activity. , 1994, The EMBO journal.
[27] David Haigh,et al. Non thiazolidinedione antihyperglycaemic agents. 2: α-Carbon substituted β-phenylpropanoic acids1 , 1996 .
[28] Peter J. Brown,et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .
[29] R. Evans,et al. The steroid and thyroid hormone receptor superfamily. , 1988, Science.
[30] C. Glass,et al. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators , 1998, Nature.
[31] H. Keen. Insulin resistance and the prevention of diabetes mellitus. , 1994, The New England journal of medicine.
[32] J. Lehmann,et al. An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.
[33] D. Barettino,et al. Characterization of the ligand‐dependent transactivation domain of thyroid hormone receptor. , 1994, The EMBO journal.
[34] P. Chambon,et al. Suprabasal expression of a dominant-negative RXR alpha mutant in transgenic mouse epidermis impairs regulation of gene transcription and basal keratinocyte proliferation by RAR-selective retinoids. , 1997, Genes & development.
[35] Z. Wu,et al. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids , 1996, Molecular and cellular biology.
[36] C. Glass,et al. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding , 1994, Nature.
[37] P. Chambon,et al. TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors. , 1996, The EMBO journal.
[38] K. Umesono,et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Lehmann,et al. The structure - Activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones , 1996 .
[40] Mary E. McGrath,et al. A structural role for hormone in the thyroid hormone receptor , 1995, Nature.
[41] B. Spiegelman,et al. Differential activation of adipogenesis by multiple PPAR isoforms. , 1996, Genes & development.
[42] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[43] M. Rao,et al. Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma. , 1996, Gene expression.
[44] Jean-Paul Renaud,et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.
[45] Barry M. Forman,et al. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ , 1997 .